Cellectis Allogeneic CAR-T Cells

InfoWeb Marketplace

mardi 15 janvier 2019Description
Cellectis focuses on using its gene editing technology, TALEN®, to create allogeneic CAR-T cells to fight cancer within the human body. Learn more about the history of this technology, the gene editing process and how it works.

Recherches associées à Biotechnologie blanche

Devis groupés (0)